Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists

This publication has 63 references indexed in Scilit:

• A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological research
  Brain Research, 2007
• Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors
  Biochemical Pharmacology, 2007
• Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugs
  Peptides, 2005
• Enteric motor and interneuronal circuits controlling motility
  Neurogastroenterology & Motility, 2004
• Pharmacological Profile of (2 R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor Antagonist
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Serotonin 5-HT 3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
• Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation
  Pharmacology & Therapeutics, 1997
• Physiology of Chemotherapy-Induced Emesis and Antiemetic Therapy
  Drugs, 1997
• Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets
  Neuropharmacology, 1996
• Rôle de la substance P dans le contrôle nerveux de la motricité digestive
  Archives Internationales de Physiologie, de Biochimie et de Biophysique, 1991